Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LIPE | Q05469 | 12/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21657013 | 0.88 | LMNA (0.42) | LMNASCN9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL21656972 | 0.88 | MAPT (0.48) | LMNAALDH1A1LIPEMAPT | |
| SCHEMBL21656859 | 0.87 | OPRM1 (0.49) | LMNA | |
| SCHEMBL23228794 | 0.86 | HPGD (0.56) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL21656977 | 0.86 | LMNA (0.57) | LMNAALDH1A1LIPEMAPT | |
| SCHEMBL21656893 | 0.85 | OPRM1 (0.49) | LMNAHPGDSMN1; SMN2LIPEHRH3 | |
| SCHEMBL21656983 | 0.85 | PDE4B (0.50) | LMNASCN9ALIPEMAPT | |
| SCHEMBL21656866 | 0.85 | LMNA (0.45) | LMNALIPE | |
| SCHEMBL21628717 | 0.82 | LMNA (0.47) | LMNAALDH1A1HPGDSMN1; SMN2LIPE | |
| SCHEMBL23228802 | 0.82 | SMN1; SMN2 (0.35) | LMNASCN9AALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885SCN9A 4485/4885ALDH1A1 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.